SBI Okasan Asset Management »

Eyepoint Pharmaceuticals shares owned by SBI Okasan Asset Management

Quarter-by-quarter ownership of Eyepoint Pharmaceuticals (EYPT) shares owned by SBI Okasan Asset Management from 13F filings

Historical chart of SBI Okasan Asset Management investment in Eyepoint Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Eyepoint Pharmaceuticals held by SBI Okasan Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Eyepoint Pharmaceuticals by SBI Okasan Asset Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $542k 46k 11.85

More positions owned by SBI Okasan Asset Management

Vanguard Total Stock Mkt Etf Total Stk Mkt (VTI)
Ishr Ibx Usd Hiyld Cb Etf-ui Iboxx Hi Yd Etf (HYG)
Ishares Jp Morgan Usd Emergi Jpmorgan Usd Emg (EMB)
Vanguard Ftse Developed Etf Van Ftse Dev Mkt (VEA)
Spdr Gold Minishares Trust Spdr Gld Minis (GLDM)
Vanguard Ftse Emerging Marke Ftse Emr Mkt Etf (VWO)
NVIDIA Corporation (NVDA)
Alphabet Inc-cl A Cap Stk Cl A (GOOGL)
Microsoft Corporation (MSFT)
Ishares Semiconductor Etf Ishares Semicdtr (SOXX)
Apple (AAPL)
Tesla Motors (TSLA)
Amazon (AMZN)
Ss Technology Select Sector State Street Tec (XLK)
Broadcom (AVGO)

View all positions for SBI Okasan Asset Management

Top funds holding Eyepoint Pharmaceuticals

Suvretta Capital Management
Cormorant Asset Management
BlackRock
Federated Investors
Franklin Resources
Vanguard Group
Adage Capital Partners GP
Henderson Group
Vanguard Capital Management
Paradigm Biocapital Advisors
Commodore Capital
Citadel Advisors
Geode Capital Management
State Street Corporation
Standard Life Aberdeen

View all funds holding Eyepoint Pharmaceuticals